leisure time
Previous article:
Walensky prepares to leave CDC — and Congress — behind
Next article: Questions loom on AstraZeneca cancer drug as safety concerns ebb
Next article: Questions loom on AstraZeneca cancer drug as safety concerns ebb
leisure time
explore
-
FDA clears Verve to begin U.S. study of gene
2025-09-28 02:20 -
Amid AI frenzy, a top HHS official's quest to create safeguards
2025-09-28 02:01 -
STAT Readout Newsletter: Biotech news today
2025-09-28 01:23 -
President Biden's budget: Here's what you might have missed
2025-09-28 01:02 -
Study on Amgen’s bispecific immunotherapy produces positive data
2025-09-28 00:10 -
ADCs take center stage as promising cancer treatments
2025-09-28 00:05